{"id":"NCT00692770","sponsor":"Bayer","briefTitle":"Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)","officialTitle":"A Phase III Randomized, Double-blind, Placebo-controlled Study of Sorafenib as Adjuvant Treatment for Hepatocellular Carcinoma After Surgical Resection or Local Ablation.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-08-15","primaryCompletion":"2013-11-29","completion":"2014-11-28","firstPosted":"2008-06-06","resultsPosted":"2014-12-01","lastUpdate":"2018-08-08"},"enrollment":1114,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Carcinoma, Hepatocellular"],"interventions":[{"type":"DRUG","name":"Nexavar (Sorafenib, BAY43-9006)","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Sorafenib (Nexavar, BAY43-9006)","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To evaluate efficacy and safety of sorafenib versus placebo in the adjuvant treatment of Hepatocellular Carcinoma (HCC) after potentially curative treatment (surgical resection or local ablation).","primaryOutcome":{"measure":"Recurrence Free Survival (RFS) by Independent Assessment","timeFrame":"From randomization up to 4 years or until disease recurrence whichever came first","effectByArm":[{"arm":"Sorafenib (Nexavar, BAY43-9006)","deltaMin":1014,"sd":null},{"arm":"Placebo","deltaMin":1026,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"=0.258329"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":18},"locations":{"siteCount":199,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Bulgaria","Canada","Chile","China","France","Germany","Greece","Hong Kong","Italy","Japan","Mexico","New Zealand","Portugal","Romania","Russia","Singapore","South Korea","Spain","Sweden","Switzerland","Taiwan","United Kingdom"]},"refs":{"pmids":["26361969","30108162","27887632","22212936","19806596"],"seeAlso":["http://www.clinicaltrialsregister.eu/"]},"adverseEventsSummary":{"seriousAny":{"events":230,"n":548},"commonTop":["Palmar-plantar erythrodysaesthesia syndrome","Diarrhoea","Hypertension","Alopecia","Fatigue"]}}